• Profile
Close

The diagnostic and predictive efficacy of 18 F-FDG PET/CT metabolic parameters for EGFR mutation status in non-small-cell lung cancer: A meta-analysis

European Journal of Radiology Jun 01, 2021

Guo Y, Zhu H, Yao Z, et al. - This study was undertaken to explore the predictive performance of the maximum standardized uptake value (SUV max ) and mean standardized uptake value (SUV mean) of primary lesions based on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) for epidermal growth factor receptor (EGFR) mutation status in patients with non-small cell lung cancer (NSCLC). Researchers enrolled 18 studies that had a total of 4,024 patients. They carried out searches of PubMed/Medline, Embase, Cochrane Library, and Web of Science databases as of January 1, 2021. They estimated pooled sensitivity, specificity, and area under the summary receiver operating characteristic curve (AUROC). Via meta-regression, the possible causes of heterogeneity were examined. The findings suggested that SUV max and SUV mean of primary lesions from 18 F-FDG PET/CT harboured moderate predictive efficacy for the EGFR mutation status of NSCLC.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay